These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sensory organization for balance: specific deficits in Alzheimer's but not in Parkinson's disease. Chong RK; Horak FB; Frank J; Kaye J J Gerontol A Biol Sci Med Sci; 1999 Mar; 54(3):M122-8. PubMed ID: 10191839 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Progressive Visual Dysfunction and Retinal Degeneration in Patients With Parkinson's Disease. Satue M; Rodrigo MJ; Obis J; Vilades E; Gracia H; Otin S; Fuertes MI; Alarcia R; Crespo JA; Polo V; Larrosa JM; Pablo LE; Garcia-Martin E Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1151-1157. PubMed ID: 28208185 [TBL] [Abstract][Full Text] [Related]
7. Functional and morphological assessment of ocular structures and follow-up of patients with early-stage Parkinson's disease. Hasanov S; Demirkilinc Biler E; Acarer A; Akkın C; Colakoglu Z; Uretmen O Int Ophthalmol; 2019 Jun; 39(6):1255-1262. PubMed ID: 29744762 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Marziani E; Pomati S; Ramolfo P; Cigada M; Giani A; Mariani C; Staurenghi G Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):5953-8. PubMed ID: 23920375 [TBL] [Abstract][Full Text] [Related]
9. Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD). Nowacka B; Lubiński W; Honczarenko K; Potemkowski A; Safranow K Doc Ophthalmol; 2015 Oct; 131(2):95-104. PubMed ID: 25972299 [TBL] [Abstract][Full Text] [Related]
10. The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease. Bayhan HA; Aslan Bayhan S; Tanık N; Gürdal C Curr Eye Res; 2014 Nov; 39(11):1117-22. PubMed ID: 24655112 [TBL] [Abstract][Full Text] [Related]
11. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease. Lee JY; Kim JM; Ahn J; Kim HJ; Jeon BS; Kim TW Mov Disord; 2014 Jan; 29(1):61-7. PubMed ID: 23775932 [TBL] [Abstract][Full Text] [Related]
12. Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson's disease. Stemplewitz B; Keserü M; Bittersohl D; Buhmann C; Skevas C; Richard G; Hassenstein A Acta Ophthalmol; 2015 Dec; 93(8):e672-7. PubMed ID: 26066643 [TBL] [Abstract][Full Text] [Related]
13. OCT in Alzheimer's disease: thinning of the RNFL and superior hemiretina. Cunha JP; Proença R; Dias-Santos A; Almeida R; Águas H; Alves M; Papoila AL; Louro C; Castanheira-Dinis A Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1827-1835. PubMed ID: 28643042 [TBL] [Abstract][Full Text] [Related]
14. [A clinical study of changes in retina and visual field in patients with early Parkinson's disease]. Li L; Ji X; Mao C; Chen Y; Guo S; Li S; Liu C Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):521-4. PubMed ID: 26359014 [TBL] [Abstract][Full Text] [Related]
15. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease. Yang ZJ; Wei J; Mao CJ; Zhang JR; Chen J; Ji XY; Liu JY; Shen Y; Xiong KP; Huang JY; Yang YP; Liu CF Sleep Breath; 2016 Dec; 20(4):1285-1292. PubMed ID: 27259748 [TBL] [Abstract][Full Text] [Related]
16. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. Garcia-Martin E; Satue M; Fuertes I; Otin S; Alarcia R; Herrero R; Bambo MP; Fernandez J; Pablo LE Ophthalmology; 2012 Oct; 119(10):2161-7. PubMed ID: 22749083 [TBL] [Abstract][Full Text] [Related]
17. Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases. Doustar J; Torbati T; Black KL; Koronyo Y; Koronyo-Hamaoui M Front Neurol; 2017; 8():701. PubMed ID: 29312125 [TBL] [Abstract][Full Text] [Related]
18. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease. Cheung CY; Ong YT; Hilal S; Ikram MK; Low S; Ong YL; Venketasubramanian N; Yap P; Seow D; Chen CL; Wong TY J Alzheimers Dis; 2015; 45(1):45-56. PubMed ID: 25428254 [TBL] [Abstract][Full Text] [Related]
19. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects]. Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761 [TBL] [Abstract][Full Text] [Related]